Results of a study investigating nivolumab for treatment of relapsed Hodgkin lymphoma.
Home / Resource Library / Nivolumab for relapsed and refractory classical Hodgkin lymphoma: retrospective single center analysis
Results of a study investigating nivolumab for treatment of relapsed Hodgkin lymphoma.